Design, synthesis, and anticancer evaluation of Biginelli-derived DHPM–amide hybrids bearing clinically inspired kinase-directed pharmacophores: EGFR docking and DFT studies
RSC Advances · 2026 · 16 (48) · 64112-64127
DOI: 10.1039/d6ra08838d ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Advances, 2026. Verfasst von Sagar P Kothadiya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Atamiya University Rajkot 360005 Gujarat India Suresh.koradiya@gmail.com. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Biginelli-derived DHPM–amide hybrids were synthesized and evaluated for anticancer activity. Compound 10b showed the highest A549 cytotoxicity and favourable EGFR-binding interactions, supported by docking and DFT studies.
Autor:innen und Institutionen
- Department of Chemistry, Atamiya University Rajkot 360005 Gujarat India Suresh.koradiya@gmail.com.
- Department of Chemistry, Shri M. P. Pandya Science College, Shri Govind Guru University Lunawada-389230 Godhra Gujarat India dryobhola@gmail.com.
ORCID-Profile: Yogesh O Bhola
Zitieren
APA
Kothadiya, S. P., Maheta, J. B., Lakhnotra, D. K., Bhola, Y. O., & Koradiya, S. B. (2026). Design, synthesis, and anticancer evaluation of Biginelli-derived DHPM–amide hybrids bearing clinically inspired kinase-directed pharmacophores: EGFR docking and DFT studies. RSC Advances, 16(48), 64112-64127. https://doi.org/10.1039/d6ra08838d
Vancouver
Kothadiya SP, Maheta JB, Lakhnotra DK, Bhola YO, Koradiya SB. Design, synthesis, and anticancer evaluation of Biginelli-derived DHPM–amide hybrids bearing clinically inspired kinase-directed pharmacophores: EGFR docking and DFT studies. RSC Advances. 2026;16(48):64112-64127. doi:10.1039/d6ra08838d
BibTeX
@article{Kothadiya2026,
author = {Kothadiya, Sagar P and Maheta, Jay B and Lakhnotra, Darshna K and Bhola, Yogesh O and Koradiya, Sureshkumar B},
title = {Design, synthesis, and anticancer evaluation of Biginelli-derived DHPM–amide hybrids bearing clinically inspired kinase-directed pharmacophores: EGFR docking and DFT studies},
journal = {RSC Advances},
year = {2026},
volume = {16},
number = {48},
pages = {64112--64127},
doi = {10.1039/d6ra08838d}
}
EUVIMED